Valproic acid is contraindicated in patients with active liver disease due to its high risk of hepatotoxicity and potential for severe liver injury.
Contraindicated in active hepatic disease or significant hepatic impairment.
Highest risk in children under 2 years or those with mitochondrial disorders.
Baseline and frequent LFT monitoring essential if used.
Discontinue immediately if LFTs elevate >2-3x upper limit of normal.
Valproic acid is primarily metabolized in the liver via glucuronidation and mitochondrial beta-oxidation; in liver dysfunction, reduced metabolic capacity leads to accumulation of toxic metabolites, exacerbating hepatotoxicity through mechanisms like mitochondrial dysfunction and oxidative stress.
Increased risk of acute liver failure, hyperammonemia, elevated liver enzymes, and potentially fatal hepatic necrosis; symptoms may include jaundice, encephalopathy, and coagulopathy.
Avoid valproic acid in patients with liver dysfunction; if unavoidable (e.g., for seizure control), use lowest effective dose with close monitoring of liver function tests (LFTs) every 1-2 weeks initially, and consider alternative therapies.
Was this helpful?
The content on SafeTo is for informational purposes only and does not constitute medical, veterinary, or professional advice. Always consult with a qualified professional for specific concerns.
Hot chocolate contains small amounts of tyramine and phenylethylamine, which can interact with MAOIs, potentially leading to a hypertensive crisis if consumed in large quantities, though the risk is generally low with moderate intake.
Kale, a vitamin K-rich leafy green, can interact with warfarin by potentially reducing its anticoagulant effects if intake is inconsistent or excessive.
Large amounts of lime juice may mildly interact with certain statins, similar to but less potent than grapefruit juice, by inhibiting drug metabolism and potentially increasing statin levels in the blood.